Disseminated intravascular coagulation in pregnancy: Insights in pathophysiology, diagnosis and management

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 4, 2015, Pages 452-463

  Erez, Offer ^a   Mastrolia, Salvatore Andrea ^a,b   Thachil, Jecko ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b POLICLINICO   (Italy)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

acute fatty liver of pregnancy; endothelial dysfunction; hemolysis elevated liver enzymes, and low platelet count (HELLP) syndrome; hemorrhage; score; trophoblast

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

BLEEDING; BLOOD CLOTTING; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIAL DYSFUNCTION; FATTY LIVER; FEMALE; HELLP SYNDROME; HUMAN; LIVER FUNCTION; NONHUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTE ACTIVATION; TROPHOBLAST; DISSEMINATED INTRAVASCULAR COAGULATION; ECLAMPSIA; FETUS; PATHOPHYSIOLOGY; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY COMPLICATIONS, HEMATOLOGIC; SEPTIC ABORTION; SOLUTIO PLACENTAE; STILLBIRTH; UTERUS BLEEDING; UTERUS RUPTURE;

ABORTION, SEPTIC; ABRUPTIO PLACENTAE; DISSEMINATED INTRAVASCULAR COAGULATION; ECLAMPSIA; FATTY LIVER; FEMALE; FETUS; HELLP SYNDROME; HUMANS; POSTPARTUM HEMORRHAGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; STILLBIRTH; UTERINE HEMORRHAGE; UTERINE RUPTURE;

EID: 84942296670     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.03.054     Document Type: Review

References (115)

1. M. Walfish, A. Neuman, and D. Wlody Maternal haemorrhage Br J Anaesth 103 Suppl 1 2009 i47 i56
2. B. Brenner, A. Aharon, and N. Lanir Hemostasis in normal pregnancy Thromb Res 115 Suppl 1 2005 6 10
3. B. Brenner Haemostatic changes in pregnancy Thromb Res 114 2004 409 414
4. D.D. Rattray, C.M. O'Connell, and T.F. Baskett Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009) J Obstet Gynaecol Can 34 2012 341 347
5. O. Erez, L. Novack, R. Beer-Weisel, and et al. DIC score in pregnant women - a population based modification of the International Society on Thrombosis and Hemostasis score PLoS One 9 2014 e93240
6. J. Thachil, and C.H. Toh Disseminated intravascular coagulation in obstetric disorders and its acute haematological management Blood Rev 23 2009 167 176
7. C.J. Berg, W.M. Callaghan, C. Syverson, and Z. Henderson Pregnancy-related mortality in the United States, 1998 to 2005 Obstet Gynecol 116 2010 1302 1309
8. M. Montagnana, M. Franchi, E. Danese, F. Gotsch, and G.C. Guidi Disseminated intravascular coagulation in obstetric and gynecologic disorders Semin Thromb Hemost 36 2010 404 418
9. M. Levi Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period Thromb Res 123 Suppl 2 2009 S63 S64
10. M. Levi Disseminated intravascular coagulation Crit Care Med 35 2007 2191 2195
11. S.H. Slofstra, C.A. Spek, and H. ten Cate Disseminated intravascular coagulation Hematol J 4 2003 295 302
12. M. Levi, and T. van der Poll Disseminated intravascular coagulation: a review for the internist Intern Emerg Med 8 2013 23 32
13. M. Levi, C.H. Toh, J. Thachil, and H.G. Watson Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology Br J Haematol 145 2009 24 33
14. H. Wada, J. Thachil, M. Di Nisio, and et al. Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal J Thromb Haemost 11 2013 2078 2079
15. C.H. Toh, and Y. Alhamdi Current consideration and management of disseminated intravascular coagulation Hematology Am Soc Hematol Educ Program 2013 2013 286 291
16. N. Hossain, and M.J. Paidas Disseminated intravascular coagulation Semin Perinatol 37 2013 257 266
17. I. Dalainas Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review Eur Rev Med Pharmacol Sci 12 2008 19 31
18. M. Levi, and H. Ten Cate Disseminated intravascular coagulation N Engl J Med 341 1999 586 592
19. U. Seligsohn Disseminated intravascular coagulation R.I. Handin, S.E. Lux, TP S Blood: principles and practice of hematology 2000 J. B. Lippingcott Philadelphia
20. G. Sher Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy Am J Obstet Gynecol 129 1977 164 170
21. A.A. Anas, W.J. Wiersinga, A.F. de Vos, and T. van der Poll Recent insights into the pathogenesis of bacterial sepsis Neth J Med 68 2010 147 152
22. H. Takai, E. Kondoh, Y. Sato, K. Kakui, K. Tatsumi, and I. Konishi Disseminated intravascular coagulation as the presenting sign of gastric cancer during pregnancy J Obstet Gynaecol Res 37 2011 1717 1719
23. M. Levi Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism) Thromb Res 131 Suppl 1 2013 S32 S34
24. M. Levi, and T. van der Poll Inflammation and coagulation Crit Care Med 38 2010 S26 S34
25. O. Erez, F. Gotsch, S. Mazaki-Tovi, and et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death J Matern Fetal Neonatal Med 22 2009 672 687
26. Y. Seki, H. Wada, K. Kawasugi, and et al. A prospective analysis of disseminated intravascular coagulation in patients with infections Intern Med 52 2013 1893 1898
27. J.Y. Sung, J.E. Kim, K.S. Kim, K.S. Han, and H.K. Kim Differential expression of leukocyte receptors in disseminated intravascular coagulation: prognostic value of low protein C receptor expression Thromb Res 134 2014 1130 1134
28. S. Kvolik, M. Jukic, M. Matijevic, K. Marjanovic, and L. Glavas-Obrovac An overview of coagulation disorders in cancer patients Surg Oncol 19 2010 e33 e46
29. B. Osterud Tissue factor expression by monocytes: regulation and pathophysiological roles Blood Coagul Fibrinolysis 9 Suppl 1 1998 S9 S14
30. M. Levi, E. de Jonge, and T. van der Poll Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation Crit Care Med 29 2001 S90 S94
31. Q. Choi, K.H. Hong, J.E. Kim, and H.K. Kim Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection Ann Lab Med 34 2014 85 91
32. G. Himmelreich, M. Jochum, W.O. Bechstein, and et al. Mediators of leukocyte activation play a role in disseminated intravascular coagulation during orthotopic liver transplantation Transplantation 57 1994 354 358
33. C.T. Esmon Role of coagulation inhibitors in inflammation Thromb Haemost 86 2001 51 56
34. M. Levi The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis Crit Care Med 30 2002 1914 1915
35. E.C. Löwenberg, J.C. Meijers, and M. Levi Platelet-vessel wall interaction in health and disease Neth J Med 68 2010 242 251
36. B. Furie, and B.C. Furie Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation Trends Mol Med 10 2004 171 178
37. N. Naccasha, M.T. Gervasi, T. Chaiworapongsa, and et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection Am J Obstet Gynecol 185 2001 1118 1123
38. G.P. Sacks, K. Studena, K. Sargent, and C.W. Redman Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis Am J Obstet Gynecol 179 1998 80 86
39. A. Zhu, R. Romero, J.B. Huang, A. Clark, and H.R. Petty Maltooligosaccharides from JEG-3 trophoblast-like cells exhibit immunoregulatory properties Am J Reprod Immunol 65 2011 54 64
40. R. Romero, N. Kadar, E. Vaisbuch, and S.S. Hassan Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol 64 2010 113 125
41. M. Seppälä, T. Wahlström, and H. Bohn Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast Int J Cancer 24 1979 6 10
42. B.C. Obiekwe, and T. Chard Placental protein 5: circulating levels in twin pregnancy and some observations on the analysis of biochemical data from multiple pregnancy Eur J Obstet Gynecol Reprod Biol 12 1981 135 141
43. Than G, Bohn H, Szabo D. Advances in pregnancy-related protein research. Boca Raton (FL); 1993.
44. P. Reverdiau, A.C. Jarousseau, G. Thibault, and et al. Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture Thromb Haemost 73 1995 49 54
45. A. Aharon, B. Brenner, T. Katz, Y. Miyagi, and N. Lanir Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis Thromb Haemost 92 2004 776 786
46. F. Hubé, P. Reverdiau, S. Iochmann, S. Trassard, G. Thibault, and Y. Gruel Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas Biol Reprod 68 2003 1888 1894
47. K. Udagawa, Y. Miyagi, F. Hirahara, and et al. Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization Placenta 19 1998 217 223
48. J.W. van Wersch, and J.M. Ubachs Blood coagulation and fibrinolysis during normal pregnancy Eur J Clin Chem Clin Biochem 29 1991 45 50
49. A.O. Robb, N.L. Mills, J.N. Din, and et al. Acute endothelial tissue plasminogen activator release in pregnancy J Thromb Haemost 7 2009 138 142
50. C.H. Toh Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction Blood Coagul Fibrinolysis 14 Suppl 1 2003 S69 S71
51. P. Chabloz, G. Reber, F. Boehlen, P. Hohlfeld, and P. de Moerloose TAFI antigen and D-dimer levels during normal pregnancy and at delivery Br J Haematol 115 2001 150 152
52. Y. Oyelese, and C.V. Ananth Placental abruption Obstet Gynecol 108 2006 1005 1016
53. G. Krikun, S.T. Huang, F. Schatz, C. Salafia, C. Stocco, and C.J. Lockwood Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction Thromb Haemost 97 2007 245 253
54. C.L. Schneider The active principle of placental toxin; thromboplastin; its inactivator in blood; antithromboplastin Am J Physiol 149 1947 123 129
55. C. McLintock, and A.H. James Obstetric hemorrhage J Thromb Haemost 9 2011 1441 1451
56. C.P. Weiner The obstetric patient and disseminated intravascular coagulation Clin Perinatol 13 1986 705 717
57. M. Grönvall, M. Tikkanen, M. Metsätähti, M. Loukovaara, J. Paavonen, and V. Stefanovic Pelvic arterial embolization in severe obstetric hemorrhage Acta Obstet Gynecol Scand 93 2014 716 719
58. W.H. Rath Postpartum hemorrhage - update on problems of definitions and diagnosis Acta Obstet Gynecol Scand 90 2011 421 428
59. C.J. Lockwood Pregnancy-associated changes in the hemostatic system Clin Obstet Gynecol 49 2006 836 843
60. J. Kuczyński, W. Uszyński, E. Zekanowska, T. Soszka, and M. Uszyński Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium Eur J Obstet Gynecol Reprod Biol 105 2002 15 19
61. K. de Boer, J.W. ten Cate, A. Sturk, J.J. Borm, and P.E. Treffers Enhanced thrombin generation in normal and hypertensive pregnancy Am J Obstet Gynecol 160 1989 95 100
62. F.K. Beller, and C. Ebert The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium Eur J Obstet Gynecol Reprod Biol 13 1982 177 197
63. M.A. Castro, T.M. Goodwin, K.J. Shaw, J.G. Ouzounian, and W.G. McGehee Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy Am J Obstet Gynecol 174 1996 211 216
64. H. Reyes, L. Sandoval, A. Wainstein, and et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients Gut 35 1994 101 106
65. P.J. Pockros, R.L. Peters, and T.B. Reynolds Idiopathic fatty liver of pregnancy: findings in ten cases Medicine (Baltimore) 63 1984 1 11
66. C.A. Riely, P.S. Latham, R. Romero, and T.P. Duffy Acute fatty liver of pregnancy. A reassessment based on observations in nine patients Ann Intern Med 106 1987 703 706
67. D.N. Slater, and W.M. Hague Renal morphological changes in idiopathic acute fatty liver of pregnancy Histopathology 8 1984 567 581
68. P. Vigil-De Gracia Acute fatty liver and HELLP syndrome: two distinct pregnancy disorders Int J Gynaecol Obstet 73 2001 215 220
69. D.B. Nelson, N.P. Yost, and F.G. Cunningham Hemostatic dysfunction with acute fatty liver of pregnancy Obstet Gynecol 124 2014 40 46
70. F.B. Taylor, C.H. Toh, W.K. Hoots, H. Wada, M. Levi Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 86 2001 1327 1330
71. K. Bakhtiari, J.C. Meijers, E. de Jonge, and M. Levi Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation Crit Care Med 32 2004 2416 2421
72. H. Minakami, N. Oka, T. Sato, T. Tamada, Y. Yasuda, and N. Hirota Preeclampsia: a microvesicular fat disease of the liver? Am J Obstet Gynecol 159 1988 1043 1047
73. D.B. Rolfes, and K.G. Ishak Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases Hepatology 5 1985 1149 1158
74. J.R. Barton, C.A. Riely, T.A. Adamec, D.R. Shanklin, A.D. Khoury, and B.M. Sibai Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) Am J Obstet Gynecol 167 1992 1538 1543
75. Y. Bacq Acute fatty liver in pregnancy Gastroenterol Clin Biol 21 1997 109 115
76. D.B. Rolfes, and K.G. Ishak Liver disease in toxemia of pregnancy Am J Gastroenterol 81 1986 1138 1144
77. P.A. Van Dam, M. Renier, M. Baekelandt, P. Buytaert, and F. Uyttenbroeck Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia Obstet Gynecol 73 1989 97 102
78. T. Gasem, F.E. Al Jama, S. Burshaid, J. Rahman, S.A. Al Suleiman, and M.S. Rahman Maternal and fetal outcome of pregnancy complicated by HELLP syndrome J Matern Fetal Neonatal Med 22 2009 1140 1143
79. S. Gando, H. Wada, J. Thachil Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH) Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS) J Thromb Haemost 11 2013 826 835
80. M. Levi, and J.C. Meijers DIC: which laboratory tests are most useful? Blood Rev 25 2011 33 37
81. A. Stepanian, M. Cohen-Moatti, T. Sanglier, and et al. Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology Arterioscler Thromb Vasc Biol 31 2011 1703 1709
82. X.L. Zheng Structure-function and regulation of ADAMTS-13 protease J Thromb Haemost 11 Suppl 1 2013 11 23
83. Erez O, Romero R, Vaisbuch E, et al. A role for low activity of ADAMTS-13 in HELLP syndrome. Presented at the Annual Scientific Meeting of the Society for Gynecologic Investigation, March 17-21, 2009, Glasgow, Scotland. Poster presentation abstract number 683.
84. Erez O, Romero R, Vaisbuch E, et al. Preeclampsia is characterized by lower plasma concentrations of the von Willebrand factor cleavage protease, ADAMTS-13: a link between endothelial dysfunction and a specific deficiency of a plasma protease. Presented at the Annual Scientific Meeting of the Society for Gynecologic Investigation, March 17-21, 2009, Glasgow, Scotland. Poster presentation abstract number 684.
85. P.W. Collins, G. Lilley, D. Bruynseels, and et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study Blood 124 2014 1727 1736
86. R.E. Collis, and P.W. Collins Haemostatic management of obstetric haemorrhage Anaesthesia 70 Suppl 1 2015 78-e28
87. B. Charbit, L. Mandelbrot, E. Samain, and et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage J Thromb Haemost 5 2007 266 273
88. M. Cortet, C. Deneux-Tharaux, C. Dupont, and et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial Br J Anaesth 108 2012 984 989
89. E. Gayat, M. Resche-Rigon, O. Morel, and et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study Intensive Care Med 37 2011 1816 1825
90. S. Mallaiah, P. Barclay, I. Harrod, C. Chevannes, and A. Bhalla Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage Anaesthesia 70 2015 166 175
91. P. Sharma, and R. Saxena A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state Am J Clin Pathol 134 2010 97 102
92. M. Sivula, V. Pettilä, T.T. Niemi, M. Varpula, and A.H. Kuitunen Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation Blood Coagul Fibrinolysis 20 2009 419 426
93. O. Karlsson, A. Jeppsson, and M. Hellgren Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 23 2014 10 17
94. N.M. de Lange, M.D. Lancé, R. de Groot, E.A. Beckers, Y.M. Henskens, and H.C. Scheepers Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage Obstet Gynecol Surv 67 2012 426 435
95. S. Gando, T. Iba, Y. Eguchi, and et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria Crit Care Med 34 2006 625 631
96. M.W. Angstwurm, C.E. Dempfle, and M. Spannagl New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores Crit Care Med 34 2006 314 320 quiz 328
97. H. Asakura, H. Wada, K. Okamoto, and et al. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections Thromb Haemost 95 2006 282 287
98. S. Cavkaytar, E.N. Ugurlu, A. Karaer, O.L. Tapisiz, and N. Danisman Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 86 2007 648 651
99. T. Terao, M. Maki, and T. Ikenoue A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC Asia Oceania J Obstet Gynaecol 13 1987 1 13
100. K. Windsperger, and R. Lehner The fibrinogen/CRP ratio as a new parameter for the diagnosis of disseminated intravascular coagulation in patients with HELLP syndrome and as a predictive factor for neonatal outcome Am J Obstet Gynecol 208 2013 118.e1 118.e7
101. World Health Organization Recommendations for the prevention and treatment of postpartum haemorrhage 2012 World Health Organization Available at: http://www.who.int/reproductivehealth/publications/maternal-perinatal-health/9789241548502/en/ Accessed Nov. 1, 2013
102. American College of Obstetricians and Gynecologists Clinical management guidelines for obstetrician-gynecologists: postpartum hemorrhage. ACOG Practice bulletin no. 76 Obstet Gynecol 108 2006 1039 1047
103. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of postpartum hemorrhage. March 2011. Available at: http://www.ranzcog.edu.au/collegestatements-guidelines.html. Accessed Nov. 1, 2013.
104. Royal College of Obstetrician and Gynaecologists. Postpartum hemorrhage: prevention and management. April 2011. Available at: http://www.rcog.org.uk/womens-health/clinical-guidance/prevention-and-management-postpartum-haemorrhage-green-top-52. Accessed Nov. 1, 2013.
105. Society of Obstetricians and Gynaecologists of Canada. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. no. 235, Oct. 2009 (replaces no. 88, April 2000). Available at: http://sogc.org/guidelines/active-management-of-the-third-stage-of-labour-prevention-and-treatment-of-postpartum-hemorrhage. Accessed Nov. 1, 2013.
106. L.D. Pacheco, G.R. Saade, A.F. Gei, and G.D. Hankins Cutting-edge advances in the medical management of obstetrical hemorrhage Am J Obstet Gynecol 205 2011 526 532
107. B.E. Ickx Fluid and blood transfusion management in obstetrics Eur J Anaesthesiol 27 2010 1031 1035
108. L. Sentilhes, S. Lasocki, A.S. Ducloy-Bouthors, and et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage Br J Anaesth 114 2015 576 587
109. P. Ferrer, I. Roberts, E. Sydenham, K. Blackhall, and H. Shakur Anti-fibrinolytic agents in post partum haemorrhage: a systematic review BMC Pregnancy Childbirth 9 2009 29
110. Royal College of Obstetricians and Gynaecologists Prevention and management of postpartum haemorrhage. Guideline no. 52. Revised April 2011 2009 Royal College of Obstetricians and Gynaecologists London
111. A.J. Wikkelsø, H.M. Edwards, A. Afshari, and et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial Br J Anaesth 114 2015 623 633
112. World Health Organization WHO guidelines for the management of postpartum haemorrhage and retained placenta 2009 World Health Organization Geneva (Switzerland)
113. N. Hossain, T. Shansi, S. Haider, and et al. Use of recombinant activated factor VII for massive postpartum hemorrhage Acta Obstet Gynecol Scand 86 2007 1200 1206
114. G. Lavigne-Lissalde, A.G. Aya, F.J. Mercier, and et al. Recombinant human FVIIa for reducing the need of invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial J Thromb Haemost 13 2015 520 529
115. M. Franchini, F. Manzato, G.L. Salvagno, and G. Lippi Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review Blood Coagul Fibrinolysis 18 2007 589 593